期刊文献+

手术治疗脑胶质瘤预后的影响因素分析 被引量:7

Prognosis and influential factor analysis after glioma surgery
下载PDF
导出
摘要 目的 研究脑胶质瘤术后疗效及影响因素。方法  5 7例脑胶质瘤患者中行全切4 1例 ,次全切 16例 ,术后均采用60 钴γ射线或电子直线加速器 6MV -X线放疗 ,2 9例同时予榄香烯治疗。结果 全切术后患者 1年生存率 5 6 % ,次全切术后患者 1年生存率 19%。低分级(星形细胞瘤 +间变性星形细胞瘤 ) 1年生存率 5 5 % ,高分级 (胶质母细胞瘤 +多形性胶质母细胞瘤 ) 1年生存率 8%。放疗前卡氏评分≤ 6 0分者 1年生存率为 17% ,卡氏评分≥ 70分 1年生存率为 6 5 %。结论 手术全切、病理低分级、放疗前卡氏评分≥ 70分的患者预后较好。手术切除程度、病理分级、放疗前卡氏评分是影响预后的重要因素。 Objective It is to study the curative effect after glioma surgery and influencing factor. Methods In 57 patients, 41 patients received grossly total resection and 16 patients received grossly subtotal resection. Postoperatively, all of them received radiotherapy of 60 Co γ-ray or linac 6MV-X-ray, moreover, 29 patients in them received chemotherapy of β-elemene. Results The one-year survival rate of patients received grossly total resection was 56%, while that of patients received grossly subtotal resection was 19%. The one-year survival rate of patients with low grade glioma (astrocytoma+ anaplasia astocytoma) was 55%, while that of patients with high grade glioma (colloid blastoma+polytypic colloid blastoma) was 8%. The one-year survival rate of patients with KPS less than 60 before radiotherapy was 17%, while that of patients with KPS more than 70 was 65%. Conclusion The patients with grossly total resection, low grade glioma, KPS more than 70 have better prognosis. Extent of resection, tumor histology and KPS before radiotherapy is main influential factors of prognosis.
出处 《现代中西医结合杂志》 CAS 2004年第4期435-436,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 脑胶质瘤 预后 手术 放疗 化疗 glioma prognosis surgery radiotherapy chemotherapy
  • 相关文献

参考文献3

二级参考文献6

  • 1Galand P,Degvaef C.Cyclin PCNA immuno-staining as an alternative to tritiated thymdine pulse labelling for making 5 phase cells in paraffin section from animal and human tissues[].Cell and Tissue Kinetics.1989
  • 2Ogata K,Kurki P,Celis JE et al.Monoclonal antibodies to a nuclear protein (PCNA Cyclin) associated with DNA replication[].Experimental Cell Research.1987
  • 3Bravo R,Frank R,Blundell PA et al.Cyclin PCNA is the auxiliary protein of DNA polymerase-delta[].Nature.1987
  • 4Van Dierendonck,Wisman JH,Keijxer R et al.Cell cyclerelated staining patterns of anti -proliferating cell nuclear antigen monoclonal antibodies , comrarison with Brdurd labelling and Ki -67 staining[].American Journal of Pathology.1991
  • 5Barbareschi M,Iuzzoline P,Pennella Aet al.p53 protein expression in central nervous system neoplasm[].Journal of Clinical Pathology.1992
  • 6吕仲虹.成人大脑半球高分级胶质瘤的放疗[J].中华放射肿瘤学杂志,1994,3(3):157-160. 被引量:23

共引文献63

同被引文献35

  • 1苏科,易石坚,向征.显微手术治疗脑胶质瘤的优势分析[J].中国医药导报,2006,3(12):34-35. 被引量:23
  • 2孙建军,王振宇.恶性脑胶质瘤的局部治疗进展[J].中华医学杂志,2005,85(20):1438-1439. 被引量:16
  • 3石静滨,赵金波,张富海,曲怡,张阳,侯菊生.榄香烯颈动脉灌注联合放疗治疗脑胶质瘤疗效分析[J].肿瘤防治杂志,2005,12(10):795-795. 被引量:10
  • 4马定霞.护患间的语言沟通[J].南方护理学报,2005,12(8):80-80. 被引量:10
  • 5Ohgaki H. Epidemiology of brain tumors[J]. Methods Mol Biol, 2009,472:323 - 342.
  • 6Norden AD,Wen PY. Glioma therapy in adults[J]. Neurologist, 2006,12(6) :279- 292.
  • 7程洁.124例脑胶质瘤术后的护理观察[J].现代护理,2010,7(10):180-183.
  • 8Weisinger JR,Bellorin - Font E. Magnesium and phosphorus[J]. Lancet, 1998,352(9125) :391 - 396.
  • 9Zwinkels H,Roon K,Jeurissen FJ. Management of temozolomide toxicity by nurse practitioners in neuro - oncology[J]. Oncol Nurs Forum,2009,36(2) :225 - 231.
  • 10Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with con- comitant and adjuvant temozolomide versus radiotherapy alone on sur- vival in glioblastoma in a randomised phase Ⅲ study:S-year analysis of the EORTC-NCIC trial[ J]. Lancet Oneol,2009,10(5 ) :459-466.

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部